Sivarama Krishna Meduri, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1020 Chattanooga Ave, Ste A&b, Dalton, GA 30720 Phone: 706-226-1300 Fax: 706-275-6478 |
News Archive
Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").
In most cases, non-melanoma skin cancers are caused by overexposure to ultraviolet radiation - the invisible rays from the sun that can burn the skin. To reduce the risk of skin cancer, dermatologists encourage the public to Be Sun Smart, including limiting sun exposure and using broad-spectrum sunscreens.
The Medical Center of Aurora (TMCA) is proud to announce its designation as a Primary Stroke Center by The Joint Commission (TJC) effective October 1, 2009. The Disease Specific Certification has been awarded to only seven other hospitals in the state of Colorado.
Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.
› Verified 1 days ago